by Combat Cancer | Nov 9, 2023 | News
More than half a million new cases of bladder cancer are diagnosed globally each year, with 200,000 deaths annually. Around 75% of patients present with non-muscle-invasive bladder cancer (NMIBC), with maintenance BCG regarded as the best bladder-sparing treatment for...
by Combat Cancer | Nov 2, 2023 | News
Breaking news! A new study just published in International Urology and Nephrology (Pazir et al) demonstrates that HIVEC with mitomycin C has a similar oncological efficacy and safety profile to standard BCG therapy in high-risk, non-muscle-invasive bladder cancer...
by Combat Cancer | Oct 26, 2023 | News
In the UK, bladder cancer quietly ranks among the top ten most common cancers for both men and women. Despite its prevalence, public awareness remains dismally low, making it a low-priority issue on the public health agenda. Bladder cancer, often dubbed the...
by Combat Cancer | Oct 19, 2023 | News
Understanding Ovarian Cancer: Long Waits, Inequalities, and the Path Forward Ovarian cancer, often called the “silent killer,” poses significant challenges in terms of diagnosis and treatment. The 2022 Pathfinder Report from “Target Ovarian...
by Combat Cancer | Oct 12, 2023 | News
On the 10th of October 2023, the world came together to observe World Mental Health Day. It’s a day dedicated to discussing mental health openly and emphasising its significance, whilst also letting individuals know that seeking help is not a sign of weakness,...
Recent Comments